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Cloning of a Novel Centrin Target Peptide
Aslin M. Rodriguez, Ana M. Gomez, Belinda Pastrana.
University of Puerto Rico at Mayaguez, Mayaguez, PR, USA.
The origin of many disease states has been linked to genetic mutation, defects
in gene expression, nuclear excision repair and ribosome biogenesis. Centrin,
a calcium binding protein, has recently been found to regulate some of these
processes along other target proteins within the nucleus. One target, Krr1, con-
tains a K homology (KH) domain; which has been identified as a nucleic acid
recognition motif, required for proper processing of pre-rRNA, for synthesis of
18S rRNA, and for the assembly of the 40S subunit. Our initial findings have
identified a putative centrin binding site located within the KH domain of
Krr1 within the Homo sapiens (Hs) centrin 2 (Hscen2-HsKrr1 complex) using
bioinformatics tools. In this study, the KH domain (192 bp) was amplified by
PCR and then ligated to the expression vector pET100 which adds a His tag
to the peptide. Colony PCR was performed to identify the E. coli colonies
that have been transformed effectively with the desired recombinant. The
KH domain was then expressed in E. coli cells. To identify the presence of
this peptide in the bacteria, an SDS-PAGE was performed. The overexpressed
KH domain peptide will be purified and used for interaction studies with
Hscen2.
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Reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Blocks
Transfer of [2Fe-2S] Clusters from MitoNEET to an Apo-Acceptor
Protein
John A. Zuris1, Syed S. Ali1, Howard Yeh1, Tung A. Nguyen1,
Rachel Nechushtai2, Mark L. Paddock1, Patricia A. Jennings1.
1University of California San Diego, La Jolla, CA, USA, 2The Hebrew
University of Jerusalem, Givat Ram, Israel.
MitoNEET is the founding member of the recently discovered CDGSH family
of [2Fe-2S] proteins. Its structure contains a unique homodimeric fold with
each monomer containing one
[2Fe-2S] cluster (1). MitoNEET is
a target of the thiazolidinedione
(TZD) class of anti-diabetes drugs
(2). Recently, it was reported that
the [2Fe-2S] cluster in mitoNEET
is destabilized upon binding of
NADPH/NADPþ (3). As mito-
NEET is capable of transferring
its [2Fe-2S] clusters to an apo-
acceptor protein (4) and an obvious
question to ask is whether NADPH
binding accelerates or abrogates
cluster transfer. We show that NADPH blocks transfer of mitoNEET’s [2Fe-
2S] cluster to an apo-acceptor protein (see Figure). This suggests a likely func-
tional role for the mitoNEET:NADPH/NADPþ interaction.
(1) Paddock ML et al. (2007) PNAS 104 14342-7
(2) Colca JR et al. (2004) Am J Physiol Endocrinol Metab 286 E252-60
(3) Zhou et al. (2010) Biochemistry 49 9604-12
(4) Zuris JA et al. (2011) PNAS 108 13047-52
*Supported by the Heme and Blood Proteins Training Grant 5T32DK007233-
34
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Mapping the Inositol Hexakisphosphate Binding Sites on the Human
Fibroblast Growth Factor
Rory Henderson, T.K.S. Kumar.
University of Arkansas, Fayetteville, AR, USA.
An investigation of the characteristics of the interaction between inositol hex-
akisphosphate (IP6) and the human acidic fibroblast growth factor (hFGF-1)
was performed. Results of the Isothermal titration calorimetry experiments
suggest that binds IP6 to hFGF-1 with a high affinity. Interestingly, differen-
tial scanning calorimetry data show a significant reduction in the melting tem-
perature (Tm ) suggesting a reduction in the stability of the protein (hFGF-1)
upon binding to IP6. This is further confirmed by the increased rate of proteo-
lytic digestion of hFGF-1 in the presence of IP6 . Circular dichroism and in-
trinsic fluorescence spectroscopy data indicate that the ligand (IP6) does not
induce major secondary structural changes in the protein. 1H 15N chemical
shift data reveal that IP6 binds in the heparin binding pocket in hFGF-1.The significance of binding of IP6 to hFGF-1 and the prospects of designing
novel therapeutic principles against hFGF-1 induced pathogenesis will be
discussed.
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A Two-Photon Absorption Probe Mimicking NADPH that Inhibits the
Nitric Oxyde Synthase
Etienne Henry1, Yun Li2, Huan Wang1, Bogdan Tarus3, Chantal Dessy4,
Patrick Tauc1, Eric Deprez1, Jean-Luc Boucher2, Anny Slama-Schwok3.
1LBPA - UMR CNRS 8113, ENS CACHAN, Institut d’Alembert,
CACHAN, France, 2LCBPT - UMR CNRS 8601, Universite´ Paris Descartes,
PARIS, France, 3LVIM - UR INRA 892, JOUY EN JOSAS, France,
4Pole of Pharmacology and Therapeutics, UCL Medical School,
BRUSSELS, Belgium.
Synthesis of nitric oxide is performed by NO-synthase. The catalysis is initiated
by the combined transfer of electrons/proton from NADPH to the flavin FAD.
We have previously characterized one photoactive compound (named Nano-
trigger, NT1) [1,2] allowing to trigger and synchronize NOS activity upon light
illumination. Here, we described a new compound (NS1) with two-photon ab-
sorption properties suitable to assess the binding to the NOS protein. This fam-
ily of compounds combines a docking moiety (NADPH analog) and
a chromophore moiety responsive for light illumination. NS1 was characterized
in DMSO by an absorption maximum at 460nm and was found to be fluorescent
with an emission peak centered at 740nm upon one-photon excitation. How-
ever, the fluorescence emission was strongly sensitive to solvent polarity as evi-
denced by the significant decrease in the emission intensity in polar solvents.
The same behaviour was observed under two-photon excitation (exc,
940nm). One- and two-photon fluorescence approaches were used to assess
the binding of NS1 to the neuronal NOS. Under one-photon excitation, the
emission properties of the complex were rather difficult to interpret due to
the overlapping between the intrinsic fluorescence of nNOS and NS1 fluores-
cence. As the two-photon fluorescence of nNOS protein is very weak, the com-
plex formation was measured by monitoring the two-photon fluorescence
recovery of NS1 upon binding to nNOS. The calculated Kd value was found
to be consistent with the value characterizing NADPH binding. However, com-
petition experiments suggest that the competition between NS1 and NADPH is
more complex than expected from a one-binding site model. Our results sug-
gest that NS1 represents a promising compound for cellular applications in
two-photon fluorescence imaging.
[1] Beaumont et al., J. Am. Chem. Soc. 2007, 129, 2178-2186
[2] Beaumont et al., ChemBioChem 2009, 10, 690-701
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Kinetics of Ligand Receptor Interaction Reveals the Mode of Binding in
Cyclic Nucleotide-Activated Proteins
Sebastian Peuker1, Martin Held2, Abhishek Cukkemane3, Frank Noe2,
U. Benjamin Kaupp1, Reinhard Seifert1.
1Caesar Research Center, Bonn, Germany, 2FU Berlin, Berlin, Germany,
3Utrecht University, Utrecht, Netherlands.
Structural biology has provided a wealth of information about the three-
dimensional organization of proteins. The next ultimate goal is to watch pro-
teins in action, i.e. to study their dynamic nature. A key question in the field
of ligand-activated proteins is the mode of ligand binding - does the ligand in-
duce a conformational change in the protein - induced fit - or does the protein
preexist as an ensemble of conformations and the ligand selects the most com-
plementary one - conformational selection? The particular mode of binding de-
termines the ‘personality’ of the protein: is it highly dynamic or rather static?
Finally, it is important to know how long a protein gets activated by a particular
ligand. Therefore, the residence time of a ligand at the binding site is a signif-
icant subject.
We study here the kinetics of cAMP binding to a cyclic nucleotide-binding do-
main (CNBD) in its isolated monomeric form. CNBDs are ancient, highly con-
served domains that control a multitude of different proteins: Among them are
transcription factors (CAP), nucleotide exchange factors (EPAC), protein ki-
nases (PKA/PKG), as well as ion channels (CNG/HNC). As a model system
we have chosen a cyclic nucleotide-gated channel from Mesorhizobium loti
(MlCNG). The rate constants of ligand binding were determined using rapid
mixing techniques in conjunction with a solvatochromic, fluorescent ligand
(8 NBD cAMP). The consequence of a mutation on the rate constants reveals
the mode of ligand binding. Comparing experimental rate constants to those
calculated by a computational model provides excellent agreement. Moreover,
by studying theoretical ligands, i.e. neutralizing or inverting charges, we gained
deeper insight into the binding process.
